Pureos Bioventures

VC FirmSeries A/B, Series C & Beyond Switzerland
Website

Pureos Bioventures is a venture capital fund, which invests exclusively in private innovative drug development companies, with a special emphasis on the next generation of biological drugs and drug formats. The fund’s portfolio companies are built on scientific excellence to develop therapies across a broad indication spectrum including oncology, immunology, ophthalmology, rare diseases, and neuroscience. Pureos has built a team with deep investment, operating and clinical expertise, that strives to impact patients’ lives by advancing innovative treatments for devastating diseases.

Typical Investment

Above €3M

Funding Stage

Series A/B, Series C & Beyond

Headquarters

Switzerland